Product Usage: This product is intended for research purposes only.
All product information available on this website is for educational purposes only. Any form of bodily introduction into humans or animals is strictly prohibited by law. This product should only be handled by licensed and qualified professionals. It is not a drug, food, or cosmetic, and must not be misbranded, misused, or mislabeled as such.
RAD-140 + MK-677 + GW-501516 Value Pack
6005 in stock
4454 in stock
3658 in stock
3658 in stock
During our packaging transition, you may receive products with either our previous or updated label. Rest assured, the formulation, purity and quality remain exactly same as standards.
This research bundle combines three synthetic compounds frequently studied across complementary research pathways: RAD-140 (Testolone), a non-steroidal selective receptor modulator; GW-501516 (Cardarine), studied for metabolic pathway modulation; and MK-677 (Ibutamoren), studied for growth hormone secretagogue properties. Combined research models allow investigation into receptor selectivity, metabolic signaling, and growth hormone pathway research within a single multi-compound experimental protocol. Research applications include comparative receptor pathway studies, metabolic and growth hormone secretagogue research, and multi-pathway experimental design.
- High Purity – 99% Purity Guaranteed
- Independently Lab Tested
- Research Grade Quality
- For Laboratory Research Use Only
| Synonyms | GW-501516 + RAD-140 + MK-677 Value Pack |
|---|---|
| Total Amount of the Active Ingredient | 10 mg per capsule |
Every batch is independently lab tested for identity, purity and potency. View our lab testing program →
What distinct research pathways does each compound in this value pack address?
RAD-140 is studied for non-steroidal selective receptor modulator activity, GW-501516 for metabolic pathway modulation relevant to glucose transport and lipid metabolism research, and MK-677 for growth hormone secretagogue properties and receptor system interactions. Combined research protocols allow investigators to examine how these three distinct mechanisms may interact within multi-pathway body composition and metabolic research models.
What experimental models are used to study this three-compound combination's effects on metabolic and receptor pathways?
Cell-based receptor binding assays, metabolic flux measurements (such as glucose uptake and lipid oxidation assays), and growth hormone pathway signalling assays (such as IGF-1 level measurement in relevant experimental models) are standard methods for studying this combination, typically run across single-compound and combined-compound treatment arms for comparative analysis.
How should researchers structure comparative protocols using this three-compound value pack?
Factorial or staggered experimental designs incorporating single-compound, paired-compound, and full three-compound treatment arms allow researchers to isolate the contribution of each compound and identify any combination-specific effects on selected research endpoints, a standard approach when studying multi-pathway compound combinations.
